Rhinovirus
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 1 programs with unclassified modality
Competitive Landscape
1 companies ranked by most advanced pipeline stage
VaxartSOUTH SAN FRANCISCO, CA
2 programs2
BTA798Phase 21 trial
VapendavirPhase 2Small Molecule1 trial
Active Trials
NCT03024177Withdrawn
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
VaxartBTA798
Clinical Trials (2)
A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection
Phase 2Withdrawn
A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Start: Aug 2010Est. completion: Mar 2012
Phase 2Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space